Sirtex also last quarter had highest growth rate and revenue in companies' history and has since added 20 new centers in US and got Australian public funding for treatment to make revs jump some more.SP is only 33% of former high price after Cehalon bid and has made alot of progress in trials and growth since that bid , and sp has not reflected any of this YET.
2006 biotech winners, page-6
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)